This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
Home
>
Views
Views
CHMP adopt positive opinion on Astellas drug
by mz_loader
Safety and hygiene aspects of contrast media administration in Italy
by mz_loader
Progress with biopharmaceuticals in Europe
by mz_loader
Pharmacy in the UK: not RPSGB Mark II
by mz_loader
Sandoz receives positive EU opinion for biosimilar filgrastim
by mz_loader
Rasilez HCT receives positive opinion from the CHMP
by mz_loader
Pharmacy in the UK: putting pharmacists at the core
by mz_loader
Risk management of biosimilars in the EU
by mz_loader
The effect on pharmacy of the changing medicines landscape
by mz_loader
Murphy’s Law
by mz_loader
Automating the hospital medicines supply chain
By Ray Fitzpatrick
by mz_loader
Do closed systems make handling of chemotherapy safe?
by mz_loader
« Previous
1
…
29
30
31
32
33
…
37
Next »
Most read
1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
2
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: